BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Topics
» Immuno-oncology, BioWorld Science
Immuno-oncology, BioWorld Science
RSS
Review supports hCG as a target for cancer immunotherapy
Feb. 15, 1999
No Comments
Ligand purchases Marathon Biopharmaceuticals' assets
Feb. 15, 1999
No Comments
PSP94 suppresses prostate cancer growth in mouse model
Feb. 12, 1999
No Comments
Enrollment completed in Maxim's malginant melanoma phase III trial
Feb. 9, 1999
No Comments
Ligand receives FDA approval for Ontak as CTCL treatment
Feb. 8, 1999
No Comments
ImmunoGen and SB enter agreement for colorectal cancer treatment
Feb. 4, 1999
No Comments
Phase I clinical trial of novel cervical dysplasia Rx from StressGen
Feb. 3, 1999
No Comments
SWOG phase II study of safety and efficacy of rhIL-4 in malignant melanoma
Jan. 25, 1999
No Comments
Polish authorities allow phase II testing of Multikine
Jan. 15, 1999
No Comments
Health Canada approves new indication for Proleukin
Jan. 12, 1999
No Comments
Previous
1
2
…
876
877
878
879
880
881
882
883
884
…
915
916
Next